Cargando…
Therapeutic Approaches to Insomnia and Fatigue in Patients with Multiple Sclerosis
The prevalence of sleep disorders in individuals with multiple sclerosis (MS) is 3–5 times higher compared to the general population. Insomnia Disorder, defined as difficulty falling asleep, maintaining sleep or waking up too early, can lead to significant fatigue, the most common and disabling symp...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896778/ https://www.ncbi.nlm.nih.gov/pubmed/33623461 http://dx.doi.org/10.2147/NSS.S256676 |
_version_ | 1783653609143009280 |
---|---|
author | Drerup, Michelle Roth, Alicia Kane, Alexa Sullivan, Amy B |
author_facet | Drerup, Michelle Roth, Alicia Kane, Alexa Sullivan, Amy B |
author_sort | Drerup, Michelle |
collection | PubMed |
description | The prevalence of sleep disorders in individuals with multiple sclerosis (MS) is 3–5 times higher compared to the general population. Insomnia Disorder, defined as difficulty falling asleep, maintaining sleep or waking up too early, can lead to significant fatigue, the most common and disabling symptom of MS. In addition, fatigue and insomnia in patients with MS also can overlap with and exacerbate other psychological and physical symptoms. Cognitive behavioral therapy for insomnia (CBT-I) has been shown as an effective treatment for chronic insomnia and burgeoning research has demonstrated the effectiveness of this treatment for insomnia in individuals with a variety of comorbid medical conditions including MS. The purpose of the current review will explore the literature surrounding the prevalence and impact of sleep disorders and fatigue in MS. Additionally, this review will address practical ways to help individuals with MS manage fatigue as well as how to modify typical standard behavioral treatments for insomnia to take into account special considerations for individuals with MS based on the level of disability and other comorbid issues that impact sleep. |
format | Online Article Text |
id | pubmed-7896778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78967782021-02-22 Therapeutic Approaches to Insomnia and Fatigue in Patients with Multiple Sclerosis Drerup, Michelle Roth, Alicia Kane, Alexa Sullivan, Amy B Nat Sci Sleep Review The prevalence of sleep disorders in individuals with multiple sclerosis (MS) is 3–5 times higher compared to the general population. Insomnia Disorder, defined as difficulty falling asleep, maintaining sleep or waking up too early, can lead to significant fatigue, the most common and disabling symptom of MS. In addition, fatigue and insomnia in patients with MS also can overlap with and exacerbate other psychological and physical symptoms. Cognitive behavioral therapy for insomnia (CBT-I) has been shown as an effective treatment for chronic insomnia and burgeoning research has demonstrated the effectiveness of this treatment for insomnia in individuals with a variety of comorbid medical conditions including MS. The purpose of the current review will explore the literature surrounding the prevalence and impact of sleep disorders and fatigue in MS. Additionally, this review will address practical ways to help individuals with MS manage fatigue as well as how to modify typical standard behavioral treatments for insomnia to take into account special considerations for individuals with MS based on the level of disability and other comorbid issues that impact sleep. Dove 2021-02-16 /pmc/articles/PMC7896778/ /pubmed/33623461 http://dx.doi.org/10.2147/NSS.S256676 Text en © 2021 Drerup et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Drerup, Michelle Roth, Alicia Kane, Alexa Sullivan, Amy B Therapeutic Approaches to Insomnia and Fatigue in Patients with Multiple Sclerosis |
title | Therapeutic Approaches to Insomnia and Fatigue in Patients with Multiple Sclerosis |
title_full | Therapeutic Approaches to Insomnia and Fatigue in Patients with Multiple Sclerosis |
title_fullStr | Therapeutic Approaches to Insomnia and Fatigue in Patients with Multiple Sclerosis |
title_full_unstemmed | Therapeutic Approaches to Insomnia and Fatigue in Patients with Multiple Sclerosis |
title_short | Therapeutic Approaches to Insomnia and Fatigue in Patients with Multiple Sclerosis |
title_sort | therapeutic approaches to insomnia and fatigue in patients with multiple sclerosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896778/ https://www.ncbi.nlm.nih.gov/pubmed/33623461 http://dx.doi.org/10.2147/NSS.S256676 |
work_keys_str_mv | AT drerupmichelle therapeuticapproachestoinsomniaandfatigueinpatientswithmultiplesclerosis AT rothalicia therapeuticapproachestoinsomniaandfatigueinpatientswithmultiplesclerosis AT kanealexa therapeuticapproachestoinsomniaandfatigueinpatientswithmultiplesclerosis AT sullivanamyb therapeuticapproachestoinsomniaandfatigueinpatientswithmultiplesclerosis |